chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 97.0
Sex: M
Vaccine: COVID19-2
Symptoms: Full blood count abnormal, Gastrointestinal disorder, Haematocrit decreased, Haemoglobin decreased, Hiatus hernia
Clinical narrative: Patient is a 98 y.o. male patient of MD with history of HTN, CAD, COPD presented on 8/23/2023 with generalized weakness and fall, found to have COVID-19 infection. consulted by Hospitalists, Generic for continuation of care out of ICU.   Acute hypoxic respiratory failure Bilateral pleural effusions COVID-19 Sepsis Secondary to COVID-19 infection versus superimposed bacterial pneumonia Patient presented to the ED hypoxic and tachycardic He said there were 2 sick contacts in his home that were positive for COVID Chest CT 8/23 with evidence of bilateral pleural effusions Chest x-ray 8/23 showed volume overload with interstitial prominence and small bilateral pleural effusions IV fluid IV fluid resuscitation initiated as well as steroids given in the ED Urine antigens negative Ferritin/Pro-Cal ratio 9,560, likely COVID pneumonia rather than bacterial.   Decadron started on 8/23, given course while inpatient Remdesivir started on 8/25, completed 5-day course Currently remains stable on room air Case management consulted for disposition arrangements in anticipation of discharge 8/29 Currently medically stable for discharge   Pancytopenia, resolved Anemia of chronic illness Secondary to infection vs chronic pancytopenia vs lab error vs malignancy CBC on admission: WBCs 3.97, RBCs 2.17, hemoglobin 6.3, hematocrit 20.5, platelets 109 S/p 2 units PRBC.   Iron study showed low Fe (16), high ferritin (1434), and low TIBC (178), not conclusive, but possibly due to both iron deficiency and chronic illness.   Monitor CBC.  Hb stable at 10.3   Hyponatremia Patient presented with generalized weakness Sodium on admission 121, likely global cord deficiency versus SIADH versus reset Osmostat Has had a history of hyponatremia Urine osmolality elevated at 575, urine sodium 140 FENa 1.5% Rehydration with normal saline and P.O., goal sodium correction rate of 6 in 24 hours, goal sodium is 127 by 10:00 am 8/24 Legionella urine antigen negative Sodium currently 131   Intrathoracic stomach Hiatal hernia.   Patient has a history of reflux and is on omeprazole CTA 8/23 noted an intrathoracic stomach Continue PPI.
Age: 97.0
Sex: M
Vaccine: COVID19-2
Symptoms: Hypervolaemia, Hyponatraemia, Hypoxia, Illness, Inappropriate antidiuretic hormone secretion
Clinical narrative: Patient is a 98 y.o. male patient of MD with history of HTN, CAD, COPD presented on 8/23/2023 with generalized weakness and fall, found to have COVID-19 infection. consulted by Hospitalists, Generic for continuation of care out of ICU.   Acute hypoxic respiratory failure Bilateral pleural effusions COVID-19 Sepsis Secondary to COVID-19 infection versus superimposed bacterial pneumonia Patient presented to the ED hypoxic and tachycardic He said there were 2 sick contacts in his home that were positive for COVID Chest CT 8/23 with evidence of bilateral pleural effusions Chest x-ray 8/23 showed volume overload with interstitial prominence and small bilateral pleural effusions IV fluid IV fluid resuscitation initiated as well as steroids given in the ED Urine antigens negative Ferritin/Pro-Cal ratio 9,560, likely COVID pneumonia rather than bacterial.   Decadron started on 8/23, given course while inpatient Remdesivir started on 8/25, completed 5-day course Currently remains stable on room air Case management consulted for disposition arrangements in anticipation of discharge 8/29 Currently medically stable for discharge   Pancytopenia, resolved Anemia of chronic illness Secondary to infection vs chronic pancytopenia vs lab error vs malignancy CBC on admission: WBCs 3.97, RBCs 2.17, hemoglobin 6.3, hematocrit 20.5, platelets 109 S/p 2 units PRBC.   Iron study showed low Fe (16), high ferritin (1434), and low TIBC (178), not conclusive, but possibly due to both iron deficiency and chronic illness.   Monitor CBC.  Hb stable at 10.3   Hyponatremia Patient presented with generalized weakness Sodium on admission 121, likely global cord deficiency versus SIADH versus reset Osmostat Has had a history of hyponatremia Urine osmolality elevated at 575, urine sodium 140 FENa 1.5% Rehydration with normal saline and P.O., goal sodium correction rate of 6 in 24 hours, goal sodium is 127 by 10:00 am 8/24 Legionella urine antigen negative Sodium currently 131   Intrathoracic stomach Hiatal hernia.   Patient has a history of reflux and is on omeprazole CTA 8/23 noted an intrathoracic stomach Continue PPI.
Age: 97.0
Sex: M
Vaccine: COVID19-2
Symptoms: Infection, Intensive care, Interstitial lung disease, Iron binding capacity total decreased, Laboratory test
Clinical narrative: Patient is a 98 y.o. male patient of MD with history of HTN, CAD, COPD presented on 8/23/2023 with generalized weakness and fall, found to have COVID-19 infection. consulted by Hospitalists, Generic for continuation of care out of ICU.   Acute hypoxic respiratory failure Bilateral pleural effusions COVID-19 Sepsis Secondary to COVID-19 infection versus superimposed bacterial pneumonia Patient presented to the ED hypoxic and tachycardic He said there were 2 sick contacts in his home that were positive for COVID Chest CT 8/23 with evidence of bilateral pleural effusions Chest x-ray 8/23 showed volume overload with interstitial prominence and small bilateral pleural effusions IV fluid IV fluid resuscitation initiated as well as steroids given in the ED Urine antigens negative Ferritin/Pro-Cal ratio 9,560, likely COVID pneumonia rather than bacterial.   Decadron started on 8/23, given course while inpatient Remdesivir started on 8/25, completed 5-day course Currently remains stable on room air Case management consulted for disposition arrangements in anticipation of discharge 8/29 Currently medically stable for discharge   Pancytopenia, resolved Anemia of chronic illness Secondary to infection vs chronic pancytopenia vs lab error vs malignancy CBC on admission: WBCs 3.97, RBCs 2.17, hemoglobin 6.3, hematocrit 20.5, platelets 109 S/p 2 units PRBC.   Iron study showed low Fe (16), high ferritin (1434), and low TIBC (178), not conclusive, but possibly due to both iron deficiency and chronic illness.   Monitor CBC.  Hb stable at 10.3   Hyponatremia Patient presented with generalized weakness Sodium on admission 121, likely global cord deficiency versus SIADH versus reset Osmostat Has had a history of hyponatremia Urine osmolality elevated at 575, urine sodium 140 FENa 1.5% Rehydration with normal saline and P.O., goal sodium correction rate of 6 in 24 hours, goal sodium is 127 by 10:00 am 8/24 Legionella urine antigen negative Sodium currently 131   Intrathoracic stomach Hiatal hernia.   Patient has a history of reflux and is on omeprazole CTA 8/23 noted an intrathoracic stomach Continue PPI.
Age: 97.0
Sex: M
Vaccine: COVID19-2
Symptoms: Legionella test, Neoplasm malignant, Pancytopenia, Platelet count decreased, Pleural effusion
Clinical narrative: Patient is a 98 y.o. male patient of MD with history of HTN, CAD, COPD presented on 8/23/2023 with generalized weakness and fall, found to have COVID-19 infection. consulted by Hospitalists, Generic for continuation of care out of ICU.   Acute hypoxic respiratory failure Bilateral pleural effusions COVID-19 Sepsis Secondary to COVID-19 infection versus superimposed bacterial pneumonia Patient presented to the ED hypoxic and tachycardic He said there were 2 sick contacts in his home that were positive for COVID Chest CT 8/23 with evidence of bilateral pleural effusions Chest x-ray 8/23 showed volume overload with interstitial prominence and small bilateral pleural effusions IV fluid IV fluid resuscitation initiated as well as steroids given in the ED Urine antigens negative Ferritin/Pro-Cal ratio 9,560, likely COVID pneumonia rather than bacterial.   Decadron started on 8/23, given course while inpatient Remdesivir started on 8/25, completed 5-day course Currently remains stable on room air Case management consulted for disposition arrangements in anticipation of discharge 8/29 Currently medically stable for discharge   Pancytopenia, resolved Anemia of chronic illness Secondary to infection vs chronic pancytopenia vs lab error vs malignancy CBC on admission: WBCs 3.97, RBCs 2.17, hemoglobin 6.3, hematocrit 20.5, platelets 109 S/p 2 units PRBC.   Iron study showed low Fe (16), high ferritin (1434), and low TIBC (178), not conclusive, but possibly due to both iron deficiency and chronic illness.   Monitor CBC.  Hb stable at 10.3   Hyponatremia Patient presented with generalized weakness Sodium on admission 121, likely global cord deficiency versus SIADH versus reset Osmostat Has had a history of hyponatremia Urine osmolality elevated at 575, urine sodium 140 FENa 1.5% Rehydration with normal saline and P.O., goal sodium correction rate of 6 in 24 hours, goal sodium is 127 by 10:00 am 8/24 Legionella urine antigen negative Sodium currently 131   Intrathoracic stomach Hiatal hernia.   Patient has a history of reflux and is on omeprazole CTA 8/23 noted an intrathoracic stomach Continue PPI.
Age: 97.0
Sex: M
Vaccine: COVID19-2
Symptoms: Pneumonia bacterial, Procalcitonin, Red blood cell count decreased, Red blood cell transfusion, Sepsis
Clinical narrative: Patient is a 98 y.o. male patient of MD with history of HTN, CAD, COPD presented on 8/23/2023 with generalized weakness and fall, found to have COVID-19 infection. consulted by Hospitalists, Generic for continuation of care out of ICU.   Acute hypoxic respiratory failure Bilateral pleural effusions COVID-19 Sepsis Secondary to COVID-19 infection versus superimposed bacterial pneumonia Patient presented to the ED hypoxic and tachycardic He said there were 2 sick contacts in his home that were positive for COVID Chest CT 8/23 with evidence of bilateral pleural effusions Chest x-ray 8/23 showed volume overload with interstitial prominence and small bilateral pleural effusions IV fluid IV fluid resuscitation initiated as well as steroids given in the ED Urine antigens negative Ferritin/Pro-Cal ratio 9,560, likely COVID pneumonia rather than bacterial.   Decadron started on 8/23, given course while inpatient Remdesivir started on 8/25, completed 5-day course Currently remains stable on room air Case management consulted for disposition arrangements in anticipation of discharge 8/29 Currently medically stable for discharge   Pancytopenia, resolved Anemia of chronic illness Secondary to infection vs chronic pancytopenia vs lab error vs malignancy CBC on admission: WBCs 3.97, RBCs 2.17, hemoglobin 6.3, hematocrit 20.5, platelets 109 S/p 2 units PRBC.   Iron study showed low Fe (16), high ferritin (1434), and low TIBC (178), not conclusive, but possibly due to both iron deficiency and chronic illness.   Monitor CBC.  Hb stable at 10.3   Hyponatremia Patient presented with generalized weakness Sodium on admission 121, likely global cord deficiency versus SIADH versus reset Osmostat Has had a history of hyponatremia Urine osmolality elevated at 575, urine sodium 140 FENa 1.5% Rehydration with normal saline and P.O., goal sodium correction rate of 6 in 24 hours, goal sodium is 127 by 10:00 am 8/24 Legionella urine antigen negative Sodium currently 131   Intrathoracic stomach Hiatal hernia.   Patient has a history of reflux and is on omeprazole CTA 8/23 noted an intrathoracic stomach Continue PPI.
Age: 97.0
Sex: M
Vaccine: COVID19-2
Symptoms: Serum ferritin increased, Superinfection, Tachycardia, Urine antigen test, Urine osmolarity
Clinical narrative: Patient is a 98 y.o. male patient of MD with history of HTN, CAD, COPD presented on 8/23/2023 with generalized weakness and fall, found to have COVID-19 infection. consulted by Hospitalists, Generic for continuation of care out of ICU.   Acute hypoxic respiratory failure Bilateral pleural effusions COVID-19 Sepsis Secondary to COVID-19 infection versus superimposed bacterial pneumonia Patient presented to the ED hypoxic and tachycardic He said there were 2 sick contacts in his home that were positive for COVID Chest CT 8/23 with evidence of bilateral pleural effusions Chest x-ray 8/23 showed volume overload with interstitial prominence and small bilateral pleural effusions IV fluid IV fluid resuscitation initiated as well as steroids given in the ED Urine antigens negative Ferritin/Pro-Cal ratio 9,560, likely COVID pneumonia rather than bacterial.   Decadron started on 8/23, given course while inpatient Remdesivir started on 8/25, completed 5-day course Currently remains stable on room air Case management consulted for disposition arrangements in anticipation of discharge 8/29 Currently medically stable for discharge   Pancytopenia, resolved Anemia of chronic illness Secondary to infection vs chronic pancytopenia vs lab error vs malignancy CBC on admission: WBCs 3.97, RBCs 2.17, hemoglobin 6.3, hematocrit 20.5, platelets 109 S/p 2 units PRBC.   Iron study showed low Fe (16), high ferritin (1434), and low TIBC (178), not conclusive, but possibly due to both iron deficiency and chronic illness.   Monitor CBC.  Hb stable at 10.3   Hyponatremia Patient presented with generalized weakness Sodium on admission 121, likely global cord deficiency versus SIADH versus reset Osmostat Has had a history of hyponatremia Urine osmolality elevated at 575, urine sodium 140 FENa 1.5% Rehydration with normal saline and P.O., goal sodium correction rate of 6 in 24 hours, goal sodium is 127 by 10:00 am 8/24 Legionella urine antigen negative Sodium currently 131   Intrathoracic stomach Hiatal hernia.   Patient has a history of reflux and is on omeprazole CTA 8/23 noted an intrathoracic stomach Continue PPI.
Age: 97.0
Sex: M
Vaccine: COVID19-2
Symptoms: Urine sodium normal, White blood cell count decreased
Clinical narrative: Patient is a 98 y.o. male patient of MD with history of HTN, CAD, COPD presented on 8/23/2023 with generalized weakness and fall, found to have COVID-19 infection. consulted by Hospitalists, Generic for continuation of care out of ICU.   Acute hypoxic respiratory failure Bilateral pleural effusions COVID-19 Sepsis Secondary to COVID-19 infection versus superimposed bacterial pneumonia Patient presented to the ED hypoxic and tachycardic He said there were 2 sick contacts in his home that were positive for COVID Chest CT 8/23 with evidence of bilateral pleural effusions Chest x-ray 8/23 showed volume overload with interstitial prominence and small bilateral pleural effusions IV fluid IV fluid resuscitation initiated as well as steroids given in the ED Urine antigens negative Ferritin/Pro-Cal ratio 9,560, likely COVID pneumonia rather than bacterial.   Decadron started on 8/23, given course while inpatient Remdesivir started on 8/25, completed 5-day course Currently remains stable on room air Case management consulted for disposition arrangements in anticipation of discharge 8/29 Currently medically stable for discharge   Pancytopenia, resolved Anemia of chronic illness Secondary to infection vs chronic pancytopenia vs lab error vs malignancy CBC on admission: WBCs 3.97, RBCs 2.17, hemoglobin 6.3, hematocrit 20.5, platelets 109 S/p 2 units PRBC.   Iron study showed low Fe (16), high ferritin (1434), and low TIBC (178), not conclusive, but possibly due to both iron deficiency and chronic illness.   Monitor CBC.  Hb stable at 10.3   Hyponatremia Patient presented with generalized weakness Sodium on admission 121, likely global cord deficiency versus SIADH versus reset Osmostat Has had a history of hyponatremia Urine osmolality elevated at 575, urine sodium 140 FENa 1.5% Rehydration with normal saline and P.O., goal sodium correction rate of 6 in 24 hours, goal sodium is 127 by 10:00 am 8/24 Legionella urine antigen negative Sodium currently 131   Intrathoracic stomach Hiatal hernia.   Patient has a history of reflux and is on omeprazole CTA 8/23 noted an intrathoracic stomach Continue PPI.
Age: 11.0
Sex: M
Vaccine: COVID19-2, FLU4, HPV9, MNQ, TDAP
Symptoms: Discontinued product administered
Clinical narrative: Covid vaccine was administered before receiving notice to discard all bivalent covid vaccines
Age: 75.0
Sex: F
Vaccine: VARZOS
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: Pt did not have any adverse events. She received the 2nd shot 12 days after the first. She will be given a 3rd vaccine 2 months after the most recent.
Age: 5.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: Discontinued product administered
Clinical narrative: Covid vaccine was administered before receiving notice to discard all bivalent covid vaccines
Age: 17.0
Sex: F
Vaccine: MENB
Symptoms: Fall, Head injury, Laboratory test, Loss of consciousness, Syncope
Clinical narrative: After receiving Bexsero vaccine and finger stick, patient fainted/lost consciousness from sitting position on exam table and fell to the floor hitting the back of her head. Event was witnessed by nurse who said patient lost consciousness for 30-60 seconds, no seizure-like activity was witnessed. Nurse was walking out of the room when the patient fell off the exam table. When asked exactly what transpired, she explained that vaccine and labs were drawn without issue, patient verbalized that she was feeling fine and stayed in sitting position, nurse turned around to walk out of the room/back was to the patient and just as she was exiting the room patient slipped off the table (she believes the LOC occurred before making contact with the ground), height of the table from ground was ~30 inches.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Vertigo
Clinical narrative: Developed symptoms of vertigo with nausea for 2 days.
Age: 86.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pain in extremity
Clinical narrative: Sore arm
Age: 48.0
Sex: F
Vaccine: FLU4
Symptoms: Blood test, Laboratory test, Lymphadenopathy
Clinical narrative: 2 SWOLLEN LYMPH NODES AT THE FRONT BASE(LEFT SIDE) OF NECK (ONGOING)
Age: 65.0
Sex: F
Vaccine: FLU4
Symptoms: Condition aggravated, Fibromyalgia, Injection site pain, Injection site pruritus, Pain in extremity
Clinical narrative: 09/16/2023 left arm pain and itching from injection site to fingers, still with mild pain and itching at injection site only today 09/21/2023; 09/17/2023 severe fibromyalgia flare, lasted through 09/20/2023. I had not had a severe flare in well over a year.
Age: 69.0
Sex: M
Vaccine: FLU4, RSV, VARZOS
Symptoms: Hypertension, Pyrexia
Clinical narrative: fever, high blood pressure
Age: 68.0
Sex: F
Vaccine: PNC20
Symptoms: Chills, Injection site erythema, Injection site pruritus, Injection site swelling, Malaise
Clinical narrative: She stated that exactly 24 hours after receiving Prevnar 20 she started not feeling well. She stated that for 4 days she had a fever, chills, body aches, redness/swelling/itching at the injection site. She stated on 9/21/23 when I spoke with the patient that her arm is still swollen, red, and itchy.
Age: 68.0
Sex: F
Vaccine: PNC20
Symptoms: Pain, Pyrexia
Clinical narrative: She stated that exactly 24 hours after receiving Prevnar 20 she started not feeling well. She stated that for 4 days she had a fever, chills, body aches, redness/swelling/itching at the injection site. She stated on 9/21/23 when I spoke with the patient that her arm is still swollen, red, and itchy.
Age: 0.67
Sex: F
Vaccine: PNC15
Symptoms: Cellulitis
Clinical narrative: Cellulitis per provider Diagnosis to the left thigh
Age: 72.0
Sex: M
Vaccine: VARZOS
Symptoms: No adverse event, Wrong product administered
Clinical narrative: PATIENT CAME IN TO RECIEVE A FLU VACCINE AND A RSV VACCINE. TECHNICIAN PREPPED THE VACCINES. PHARMACIST CHECKED THE SYRINGE WITH THE FLU VACCINE AND THE SYRINGE WITH THE VACCINE MIXTURE FOR RSV. AFTER PATIENT RECEIVED THE VACCINES AND LEFT, PHARMACIST NOTICED THE BOTTLES USED FOR THE RSV MIXTURE AT THE VACCINE PREP LOCATION WAS FOR SHINGRIX INSTEAD OF RSV. CALLED PATIENTS AND THEY ARE BOTH AWARE AND UNDERSTAND. PHARMACIST WAS EXTREMELY APOLOGETIC AND OFFERED FOR THE PATIENTS TO COME IN AT THEIR CONVENIENCE TO ADMINISTER THE CORRECT VACCINE. PHARMACIST REASSURED THEM THERE WILL BE NO HARM FROM RECIEVING AN EXTRA DOSE OF SHINGRIX AND PHARMACIST OFFERED TO MIX THE VACCINES IN FRONT OF THEM AND ADMINISTER THE VACCINES HERSELF. PATIENTS WERE NOT UPSET. PATIENT NOT EXPERIENCING ANY ADVERSE REACTIONS AT THIS TIME.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Asthenia, COVID-19, Cardiac failure chronic, Cardiac telemetry abnormal
Clinical narrative: Patient is a 71 y.o. female with past medical history of essential hypertension, OSA on CPAP and oxygen at bedtime, hypertension, chronic diastolic heart failure, and morbid obesity who presented to an outside hospital on 8/16/2023 with fevers and generalized weakness, was found to have hypoxia and COVID-19, and she was transferred to  Hospital for further care.           Assessment and Plan   Acute hypoxic respiratory failure COVID-19 - Presented with: generalized weakness and headache - Symptom onset: 8/14/23 - Positive COVID-19: 8/16/23 at Med ED - Vaccination status: Received first to Pfizer shots but no boosters due to reaction to initial vaccination. - CXR on admission showed CXR on admission showed normal - Oxygen status: Room air during the day as of 8/19/2023 - Decadron: Yes. Expected end date 8/26/23 - Remdesivir: Yes. Expected end date 8/20/2023stopped due to resolution of hypoxia - DVT prophylaxis:Lovenox - Serial COVID labs ordered: Yes - Case Management/Social Services consulted: Yes -Procalcitonin only 0.07 on 8/18/2023, hence low likelihood for bacterial infection. -Continue albuterol and Tessalon perles as needed for cough/congestion -As of 8/19/2023 weaned to room air during the daytime and back to baseline. -Discharged on 8/20/2023.   Chronic heart failure with preserved ejection fraction -Mentioned in her history from OSU however per cardiology note from July 2022 there is "no evidence of heart failure/HFpEF". -Home medications include Coreg 3 mg twice daily, lisinopril 10 mg daily, and Lasix 40 mg daily. -Last echocardiogram 1/23/2023 demonstrated ejection fraction of 60% -Stable and home medications continued as before.   Bigeminy/trigeminy -Intermittent on telemetry and she had this previously at OSU on 3/31/2023 per review of their rhythm strips. -Chronic and no further evaluation warranted as she was asymptomatic and this is not a new finding.   Type 2 diabetes mellitus without complications -Patient is not on any medications for diabetes  (Patient was on metformin in the past). -A1c was 5.9 in November 2022. -Continue ongoing outpatient monitoring as before.   Essential hypertension -Home medications include Coreg 25 mg twice daily, hydralazine 25 mg 3 times daily, lisinopril 10 mg daily. -Stable and home medications continued as before.   Major depression in remission -Patient continue with home Wellbutrin 450 mg daily   OSA -Secondary to morbid obesity -She wears CPAP with 3.5 L of oxygen at bedtime at baseline. -Stable and no acute issues.   History of chronic pain syndrome Peripheral neuropathy OA -Continue with gabapentin 600 mg TID   Morbid obesity -History of gastric stapling in 1980 that was later reversed in 1981. -BMI 54.21 -Advised lifestyle changes -Patient has been getting Wegovy injections every week
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray normal, Extrasystoles, Headache, Hypoxia, Laboratory test
Clinical narrative: Patient is a 71 y.o. female with past medical history of essential hypertension, OSA on CPAP and oxygen at bedtime, hypertension, chronic diastolic heart failure, and morbid obesity who presented to an outside hospital on 8/16/2023 with fevers and generalized weakness, was found to have hypoxia and COVID-19, and she was transferred to  Hospital for further care.           Assessment and Plan   Acute hypoxic respiratory failure COVID-19 - Presented with: generalized weakness and headache - Symptom onset: 8/14/23 - Positive COVID-19: 8/16/23 at Med ED - Vaccination status: Received first to Pfizer shots but no boosters due to reaction to initial vaccination. - CXR on admission showed CXR on admission showed normal - Oxygen status: Room air during the day as of 8/19/2023 - Decadron: Yes. Expected end date 8/26/23 - Remdesivir: Yes. Expected end date 8/20/2023stopped due to resolution of hypoxia - DVT prophylaxis:Lovenox - Serial COVID labs ordered: Yes - Case Management/Social Services consulted: Yes -Procalcitonin only 0.07 on 8/18/2023, hence low likelihood for bacterial infection. -Continue albuterol and Tessalon perles as needed for cough/congestion -As of 8/19/2023 weaned to room air during the daytime and back to baseline. -Discharged on 8/20/2023.   Chronic heart failure with preserved ejection fraction -Mentioned in her history from OSU however per cardiology note from July 2022 there is "no evidence of heart failure/HFpEF". -Home medications include Coreg 3 mg twice daily, lisinopril 10 mg daily, and Lasix 40 mg daily. -Last echocardiogram 1/23/2023 demonstrated ejection fraction of 60% -Stable and home medications continued as before.   Bigeminy/trigeminy -Intermittent on telemetry and she had this previously at OSU on 3/31/2023 per review of their rhythm strips. -Chronic and no further evaluation warranted as she was asymptomatic and this is not a new finding.   Type 2 diabetes mellitus without complications -Patient is not on any medications for diabetes  (Patient was on metformin in the past). -A1c was 5.9 in November 2022. -Continue ongoing outpatient monitoring as before.   Essential hypertension -Home medications include Coreg 25 mg twice daily, hydralazine 25 mg 3 times daily, lisinopril 10 mg daily. -Stable and home medications continued as before.   Major depression in remission -Patient continue with home Wellbutrin 450 mg daily   OSA -Secondary to morbid obesity -She wears CPAP with 3.5 L of oxygen at bedtime at baseline. -Stable and no acute issues.   History of chronic pain syndrome Peripheral neuropathy OA -Continue with gabapentin 600 mg TID   Morbid obesity -History of gastric stapling in 1980 that was later reversed in 1981. -BMI 54.21 -Advised lifestyle changes -Patient has been getting Wegovy injections every week
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Left ventricular failure, Procalcitonin, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Patient is a 71 y.o. female with past medical history of essential hypertension, OSA on CPAP and oxygen at bedtime, hypertension, chronic diastolic heart failure, and morbid obesity who presented to an outside hospital on 8/16/2023 with fevers and generalized weakness, was found to have hypoxia and COVID-19, and she was transferred to  Hospital for further care.           Assessment and Plan   Acute hypoxic respiratory failure COVID-19 - Presented with: generalized weakness and headache - Symptom onset: 8/14/23 - Positive COVID-19: 8/16/23 at Med ED - Vaccination status: Received first to Pfizer shots but no boosters due to reaction to initial vaccination. - CXR on admission showed CXR on admission showed normal - Oxygen status: Room air during the day as of 8/19/2023 - Decadron: Yes. Expected end date 8/26/23 - Remdesivir: Yes. Expected end date 8/20/2023stopped due to resolution of hypoxia - DVT prophylaxis:Lovenox - Serial COVID labs ordered: Yes - Case Management/Social Services consulted: Yes -Procalcitonin only 0.07 on 8/18/2023, hence low likelihood for bacterial infection. -Continue albuterol and Tessalon perles as needed for cough/congestion -As of 8/19/2023 weaned to room air during the daytime and back to baseline. -Discharged on 8/20/2023.   Chronic heart failure with preserved ejection fraction -Mentioned in her history from OSU however per cardiology note from July 2022 there is "no evidence of heart failure/HFpEF". -Home medications include Coreg 3 mg twice daily, lisinopril 10 mg daily, and Lasix 40 mg daily. -Last echocardiogram 1/23/2023 demonstrated ejection fraction of 60% -Stable and home medications continued as before.   Bigeminy/trigeminy -Intermittent on telemetry and she had this previously at OSU on 3/31/2023 per review of their rhythm strips. -Chronic and no further evaluation warranted as she was asymptomatic and this is not a new finding.   Type 2 diabetes mellitus without complications -Patient is not on any medications for diabetes  (Patient was on metformin in the past). -A1c was 5.9 in November 2022. -Continue ongoing outpatient monitoring as before.   Essential hypertension -Home medications include Coreg 25 mg twice daily, hydralazine 25 mg 3 times daily, lisinopril 10 mg daily. -Stable and home medications continued as before.   Major depression in remission -Patient continue with home Wellbutrin 450 mg daily   OSA -Secondary to morbid obesity -She wears CPAP with 3.5 L of oxygen at bedtime at baseline. -Stable and no acute issues.   History of chronic pain syndrome Peripheral neuropathy OA -Continue with gabapentin 600 mg TID   Morbid obesity -History of gastric stapling in 1980 that was later reversed in 1981. -BMI 54.21 -Advised lifestyle changes -Patient has been getting Wegovy injections every week
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Dependence on respirator, End stage renal disease, Hydronephrosis, Hypotension, Respiratory failure
Clinical narrative: I95.9 HYPOTENSION 6/24/2023 ESRD (END STAGE RENAL DISEASE) J96.92 HYPERCAPNIC RESPIRATORY FAILURE, UNSPECIFIED ACUITY 7/22/2023 ESRD (END STAGE RENAL DISEASE) I95.9 HYPOTENSION 6/24/2023 ESRD (END STAGE RENAL DISEASE) J96.92 HYPERCAPNIC RESPIRATORY FAILURE, UNSPECIFIED ACUITY 7/22/2023 ESRD (END STAGE RENAL DISEASE) I95.9 HYPOTENSION 6/24/2023 SEPSIS WO ACUTE ORGAN DYSFUNCTION J96.92 HYPERCAPNIC RESPIRATORY FAILURE, UNSPECIFIED ACUITY 7/22/2023 SEPSIS WO ACUTE ORGAN DYSFUNCTION I95.9 HYPOTENSION 6/24/2023 RESPIRATOR DEPENDENCE J96.92 HYPERCAPNIC RESPIRATORY FAILURE, UNSPECIFIED ACUITY 7/22/2023 RESPIRATOR DEPENDENCE I95.9 HYPOTENSION 6/24/2023 HYDRONEPHROSIS J96.92 HYPERCAPNIC RESPIRATORY FAILURE, UNSPECIFIED ACUITY 7/22/2023 HYDRONEPHROSIS
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Sepsis
Clinical narrative: I95.9 HYPOTENSION 6/24/2023 ESRD (END STAGE RENAL DISEASE) J96.92 HYPERCAPNIC RESPIRATORY FAILURE, UNSPECIFIED ACUITY 7/22/2023 ESRD (END STAGE RENAL DISEASE) I95.9 HYPOTENSION 6/24/2023 ESRD (END STAGE RENAL DISEASE) J96.92 HYPERCAPNIC RESPIRATORY FAILURE, UNSPECIFIED ACUITY 7/22/2023 ESRD (END STAGE RENAL DISEASE) I95.9 HYPOTENSION 6/24/2023 SEPSIS WO ACUTE ORGAN DYSFUNCTION J96.92 HYPERCAPNIC RESPIRATORY FAILURE, UNSPECIFIED ACUITY 7/22/2023 SEPSIS WO ACUTE ORGAN DYSFUNCTION I95.9 HYPOTENSION 6/24/2023 RESPIRATOR DEPENDENCE J96.92 HYPERCAPNIC RESPIRATORY FAILURE, UNSPECIFIED ACUITY 7/22/2023 RESPIRATOR DEPENDENCE I95.9 HYPOTENSION 6/24/2023 HYDRONEPHROSIS J96.92 HYPERCAPNIC RESPIRATORY FAILURE, UNSPECIFIED ACUITY 7/22/2023 HYDRONEPHROSIS
Age: 61.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site erythema, Injection site induration, Injection site pain, Injection site warmth
Clinical narrative: Teammate had vaccine on 9/19/23, initially site was sore. Today, 9/21/23, woke up with grapefruit sized red, warm-to-touch, hardened, painful area around injection site. States pain is improving some throughout the day. Does not feel needs to be seen in OH at this time.
Age: 68.0
Sex: M
Vaccine: COVID19-2
Symptoms: Blood testosterone normal, Blood thyroid stimulating hormone normal, Fatigue, Positron emission tomogram normal
Clinical narrative: Pt with development of severe fatigue without alternative cause ~1 months after vaccination (cortisol, testosterone, TSH normal, OSA ruled out, no significant anemia)  He does not appear to have reactivation of his underlying sarcoidosis (PET scans without inflammation)
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Cellulitis, Hypotension
Clinical narrative: I95.9 HYPOTENSION 7/29/2023 CELLULITIS
Age: 92.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Angiogram pulmonary abnormal, Asthenia, Blood culture negative, C-reactive protein increased
Clinical narrative: Patient is a 93 y.o. female patient of MD with history of Alzheimer Dementia, Anemia, Seizure disorder on Keppra, CKD 3a, CAD, and HLD  presented on 8/29/2023 with SOB. Agency consulted by Hospitalists, Generic for medical management.    Acute respiratory failure with hypoxia Covid 19 PNA Multifocal PNA Pneumonia DNR CC Presented with weakness, SOB CXR 8/26 showed no acute cardiopulmonary process CXR 8/29 showed bibasilar airspace opacity CTPA 8/29 show bilateral lower lobe pneumonia AF, WBC normal, CRP 308.4, PCT 6.14, Blood culture NGTD, MRSA detected, Urine Ag negative ID and Pulm following; was needing HHF but now on RA since not keeping NC on  Resumed remdesivir (Stop 9/2), dexamethasone (stop 9/9) Rocephin and azithromycin stopped, now po Pt's mental status is waxing and waining Palliative care consulted, DNR CC, All labs, IV have been discontinued Plan to discharge to SNF then home   Acute toxic encephalopathy Likely d/t COVID and pneumonia with dementia baseline UA without infection Continues to wax and wane   Generalized weakness Decreased oral intake Likely secondary to COVID and pneumonia PT/OT/CM   History of seizures Continued home Keppra   Dementia Holding home Remeron due to hypersomnolence and AMS   Hyperlipidemia Holding home statin   History of CVA Continue home aspirin; holding statin since risks outweigh benefits
Age: 92.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Chest X-ray abnormal, Dyspnoea, Hypersomnia
Clinical narrative: Patient is a 93 y.o. female patient of MD with history of Alzheimer Dementia, Anemia, Seizure disorder on Keppra, CKD 3a, CAD, and HLD  presented on 8/29/2023 with SOB. Agency consulted by Hospitalists, Generic for medical management.    Acute respiratory failure with hypoxia Covid 19 PNA Multifocal PNA Pneumonia DNR CC Presented with weakness, SOB CXR 8/26 showed no acute cardiopulmonary process CXR 8/29 showed bibasilar airspace opacity CTPA 8/29 show bilateral lower lobe pneumonia AF, WBC normal, CRP 308.4, PCT 6.14, Blood culture NGTD, MRSA detected, Urine Ag negative ID and Pulm following; was needing HHF but now on RA since not keeping NC on  Resumed remdesivir (Stop 9/2), dexamethasone (stop 9/9) Rocephin and azithromycin stopped, now po Pt's mental status is waxing and waining Palliative care consulted, DNR CC, All labs, IV have been discontinued Plan to discharge to SNF then home   Acute toxic encephalopathy Likely d/t COVID and pneumonia with dementia baseline UA without infection Continues to wax and wane   Generalized weakness Decreased oral intake Likely secondary to COVID and pneumonia PT/OT/CM   History of seizures Continued home Keppra   Dementia Holding home Remeron due to hypersomnolence and AMS   Hyperlipidemia Holding home statin   History of CVA Continue home aspirin; holding statin since risks outweigh benefits
Age: 92.0
Sex: F
Vaccine: COVID19
Symptoms: Hypophagia, Laboratory test, Lung opacity, Mental status changes, Pneumonia
Clinical narrative: Patient is a 93 y.o. female patient of MD with history of Alzheimer Dementia, Anemia, Seizure disorder on Keppra, CKD 3a, CAD, and HLD  presented on 8/29/2023 with SOB. Agency consulted by Hospitalists, Generic for medical management.    Acute respiratory failure with hypoxia Covid 19 PNA Multifocal PNA Pneumonia DNR CC Presented with weakness, SOB CXR 8/26 showed no acute cardiopulmonary process CXR 8/29 showed bibasilar airspace opacity CTPA 8/29 show bilateral lower lobe pneumonia AF, WBC normal, CRP 308.4, PCT 6.14, Blood culture NGTD, MRSA detected, Urine Ag negative ID and Pulm following; was needing HHF but now on RA since not keeping NC on  Resumed remdesivir (Stop 9/2), dexamethasone (stop 9/9) Rocephin and azithromycin stopped, now po Pt's mental status is waxing and waining Palliative care consulted, DNR CC, All labs, IV have been discontinued Plan to discharge to SNF then home   Acute toxic encephalopathy Likely d/t COVID and pneumonia with dementia baseline UA without infection Continues to wax and wane   Generalized weakness Decreased oral intake Likely secondary to COVID and pneumonia PT/OT/CM   History of seizures Continued home Keppra   Dementia Holding home Remeron due to hypersomnolence and AMS   Hyperlipidemia Holding home statin   History of CVA Continue home aspirin; holding statin since risks outweigh benefits
Age: 92.0
Sex: F
Vaccine: COVID19
Symptoms: Staphylococcus test positive, Toxic encephalopathy, Urine analysis normal, Urine antigen test, White blood cell count normal
Clinical narrative: Patient is a 93 y.o. female patient of MD with history of Alzheimer Dementia, Anemia, Seizure disorder on Keppra, CKD 3a, CAD, and HLD  presented on 8/29/2023 with SOB. Agency consulted by Hospitalists, Generic for medical management.    Acute respiratory failure with hypoxia Covid 19 PNA Multifocal PNA Pneumonia DNR CC Presented with weakness, SOB CXR 8/26 showed no acute cardiopulmonary process CXR 8/29 showed bibasilar airspace opacity CTPA 8/29 show bilateral lower lobe pneumonia AF, WBC normal, CRP 308.4, PCT 6.14, Blood culture NGTD, MRSA detected, Urine Ag negative ID and Pulm following; was needing HHF but now on RA since not keeping NC on  Resumed remdesivir (Stop 9/2), dexamethasone (stop 9/9) Rocephin and azithromycin stopped, now po Pt's mental status is waxing and waining Palliative care consulted, DNR CC, All labs, IV have been discontinued Plan to discharge to SNF then home   Acute toxic encephalopathy Likely d/t COVID and pneumonia with dementia baseline UA without infection Continues to wax and wane   Generalized weakness Decreased oral intake Likely secondary to COVID and pneumonia PT/OT/CM   History of seizures Continued home Keppra   Dementia Holding home Remeron due to hypersomnolence and AMS   Hyperlipidemia Holding home statin   History of CVA Continue home aspirin; holding statin since risks outweigh benefits
Age: 34.0
Sex: M
Vaccine: FLU4
Symptoms: Rash
Clinical narrative: rash over body
Age: 70.0
Sex: F
Vaccine: VARZOS
Symptoms: No adverse event, Wrong product administered
Clinical narrative: PATIENT CAME IN TO RECIEVE A FLU VACCINE AND A RSV VACCINE. TECHNICIAN PREPPED THE VACCINES. PHARMACIST CHECKED THE SYRINGE WITH THE FLU VACCINE AND THE SYRINGE WITH THE VACCINE MIXTURE FOR RSV. AFTER PATIENT RECEIVED THE VACCINES AND LEFT, PHARMACIST NOTICED THE BOTTLES USED FOR THE RSV MIXTURE AT THE VACCINE PREP LOCATION WAS FOR SHINGRIX INSTEAD OF RSV. CALLED PATIENTS AND THEY ARE BOTH AWARE AND UNDERSTAND. PHARMACIST WAS EXTREMELY APOLOGETIC AND OFFERED FOR THE PATIENTS TO COME IN AT THEIR CONVENIENCE TO ADMINISTER THE CORRECT VACCINE. PHARMACIST REASSURED THEM THERE WILL BE NO HARM FROM RECIEVING AN EXTRA DOSE OF SHINGRIX AND PHARMACIST OFFERED TO MIX THE VACCINES IN FRONT OF THEM AND ADMINISTER THE VACCINES HERSELF. PATIENTS WERE NOT UPSET. PATIENT NOT EXPERIENCING ANY ADVERSE REACTIONS AT THIS TIME.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, Product administered to patient of inappropriate age
Clinical narrative: Pediatric dosing was given to adult patient
Age: 71.0
Sex: M
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, Angiogram pulmonary abnormal, COVID-19, Chronic obstructive pulmonary disease, Condition aggravated
Clinical narrative: This is a 72-year-old male with past medical history of former tobacco use, COPD, chronic respiratory failure (previously required home oxygen, currently cannot afford), hypertension, hyperlipidemia, PAD s/p aortoiliac stent/graft 2013, depression, prediabetes (A1c 6.0), who presents emergency department with progressive shortness of breath, cough for 1 week.  Patient reports his symptom onset was past Sunday, started with chest congestion, increased cough, shortness of breath, worse with exertion, generalized malaise, body aches.  Had intermittent diarrhea, denies nausea vomiting.  Denies chest pain, lightheadedness, dizziness, bleeding issues, fever.   Upon arrival patient was satting between 85 to 87% room air, p  Upon arrival patient was satting between 85 to 87% room air, placed on 2 L nasal cannula oxygen with improvement.  Received azithromycin, Solu-Medrol, bronchodilators, CTA showed no acute cardiopulmonary disease, did show advanced upper lobe predominant emphysema with 1.7 cm linear density within the right upper lung apex possibly scarring.  He is otherwise nontoxic-appearing, CODE STATUS discussed full code.   Clinical Summary Patient was admitted with above noted complaints.  He was continued on supplemental oxygen as needed.  He was started on Zithromax IV, remdesivir which was initiated with loading dose, bronchodilators, and Decadron IV for treatment of COVID-19 and COPD exacerbation.  Patient has had significant improvement in symptoms and has remained hemodynamically stable.  He has received a total of 4 doses of IV remdesivir and Decadron. He intermittently requires supplemental oxygen at rest therefore 6-minute walk test was completed which showed that oxygen saturation dropped to 87% on room air with activity.  Patient will be discharged with oxygen at 2 L via nasal cannula.  Patient has no concerns regarding discharge home today.  Prescriptions provided for dexamethasone and Zithromax p.o. to complete course.  Patient to follow-up with PCP in 3 to 5 days and also strongly encouraged to return to the ER if he develops any new or worsening symptoms. Discharge diagnosis Acute Hypoxic Respiratory Failure Acute COPD Exacerbation Acute COVID-19 Infection   Chronic conditions include: Hypertension Hyperlipidemia PVD s/p aortoiliac stent Former tobacco use Prediabetes (A1c 6.0)
Age: 71.0
Sex: M
Vaccine: COVID19-2
Symptoms: Cough, Diarrhoea, Dyspnoea, Dyspnoea exertional, Emphysema
Clinical narrative: This is a 72-year-old male with past medical history of former tobacco use, COPD, chronic respiratory failure (previously required home oxygen, currently cannot afford), hypertension, hyperlipidemia, PAD s/p aortoiliac stent/graft 2013, depression, prediabetes (A1c 6.0), who presents emergency department with progressive shortness of breath, cough for 1 week.  Patient reports his symptom onset was past Sunday, started with chest congestion, increased cough, shortness of breath, worse with exertion, generalized malaise, body aches.  Had intermittent diarrhea, denies nausea vomiting.  Denies chest pain, lightheadedness, dizziness, bleeding issues, fever.   Upon arrival patient was satting between 85 to 87% room air, p  Upon arrival patient was satting between 85 to 87% room air, placed on 2 L nasal cannula oxygen with improvement.  Received azithromycin, Solu-Medrol, bronchodilators, CTA showed no acute cardiopulmonary disease, did show advanced upper lobe predominant emphysema with 1.7 cm linear density within the right upper lung apex possibly scarring.  He is otherwise nontoxic-appearing, CODE STATUS discussed full code.   Clinical Summary Patient was admitted with above noted complaints.  He was continued on supplemental oxygen as needed.  He was started on Zithromax IV, remdesivir which was initiated with loading dose, bronchodilators, and Decadron IV for treatment of COVID-19 and COPD exacerbation.  Patient has had significant improvement in symptoms and has remained hemodynamically stable.  He has received a total of 4 doses of IV remdesivir and Decadron. He intermittently requires supplemental oxygen at rest therefore 6-minute walk test was completed which showed that oxygen saturation dropped to 87% on room air with activity.  Patient will be discharged with oxygen at 2 L via nasal cannula.  Patient has no concerns regarding discharge home today.  Prescriptions provided for dexamethasone and Zithromax p.o. to complete course.  Patient to follow-up with PCP in 3 to 5 days and also strongly encouraged to return to the ER if he develops any new or worsening symptoms. Discharge diagnosis Acute Hypoxic Respiratory Failure Acute COPD Exacerbation Acute COVID-19 Infection   Chronic conditions include: Hypertension Hyperlipidemia PVD s/p aortoiliac stent Former tobacco use Prediabetes (A1c 6.0)
Age: 71.0
Sex: M
Vaccine: COVID19-2
Symptoms: Malaise, Pain, Respiratory tract congestion
Clinical narrative: This is a 72-year-old male with past medical history of former tobacco use, COPD, chronic respiratory failure (previously required home oxygen, currently cannot afford), hypertension, hyperlipidemia, PAD s/p aortoiliac stent/graft 2013, depression, prediabetes (A1c 6.0), who presents emergency department with progressive shortness of breath, cough for 1 week.  Patient reports his symptom onset was past Sunday, started with chest congestion, increased cough, shortness of breath, worse with exertion, generalized malaise, body aches.  Had intermittent diarrhea, denies nausea vomiting.  Denies chest pain, lightheadedness, dizziness, bleeding issues, fever.   Upon arrival patient was satting between 85 to 87% room air, p  Upon arrival patient was satting between 85 to 87% room air, placed on 2 L nasal cannula oxygen with improvement.  Received azithromycin, Solu-Medrol, bronchodilators, CTA showed no acute cardiopulmonary disease, did show advanced upper lobe predominant emphysema with 1.7 cm linear density within the right upper lung apex possibly scarring.  He is otherwise nontoxic-appearing, CODE STATUS discussed full code.   Clinical Summary Patient was admitted with above noted complaints.  He was continued on supplemental oxygen as needed.  He was started on Zithromax IV, remdesivir which was initiated with loading dose, bronchodilators, and Decadron IV for treatment of COVID-19 and COPD exacerbation.  Patient has had significant improvement in symptoms and has remained hemodynamically stable.  He has received a total of 4 doses of IV remdesivir and Decadron. He intermittently requires supplemental oxygen at rest therefore 6-minute walk test was completed which showed that oxygen saturation dropped to 87% on room air with activity.  Patient will be discharged with oxygen at 2 L via nasal cannula.  Patient has no concerns regarding discharge home today.  Prescriptions provided for dexamethasone and Zithromax p.o. to complete course.  Patient to follow-up with PCP in 3 to 5 days and also strongly encouraged to return to the ER if he develops any new or worsening symptoms. Discharge diagnosis Acute Hypoxic Respiratory Failure Acute COPD Exacerbation Acute COVID-19 Infection   Chronic conditions include: Hypertension Hyperlipidemia PVD s/p aortoiliac stent Former tobacco use Prediabetes (A1c 6.0)
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, Product administered to patient of inappropriate age
Clinical narrative: Pediatric dosing was given to adult patient.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Feeling hot, Hyperhidrosis, Loss of consciousness
Clinical narrative: Next morning, I got up, went to bathroom. On the way back from the bathroom to the sofa, I became hot, sweatty and felt like I was going to pass out. I let myself to the floor gently, sweating profusely, and passed out. Not sure how much time had passed, but I came to and questioned where I was and how I got there. I crawled to the sofa. Was very weak all day. Started to feel human the next day.
Age: 13.0
Sex: M
Vaccine: MMR
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: The patient and the guardian were advised of the occurrence. The patient did not report any symptoms and was seen 9/20/2023 and was given the correct vaccine after evaluation by our Family Nurse Practitioner.
Age: 1.0
Sex: M
Vaccine: DTAP, HEPA, HIBV, MMR, PNC13, VARCEL
Symptoms: Erythema, Injection site erythema, Injection site swelling, Rash macular
Clinical narrative: redness, swelling around injections sites (both legs), face was red and splotchy.  Patient placed on pulse oximeter (100%), no difficulty breathing, no vomiting.   Patient was given 12.5mg Benadryl in response and patient was monitored for 45 minutes following adverse event and Benadryl administration.  Patient improved, only small spot of redness on left check after assessment before family left the clinic. Family felt comfortable leaving and were given return precautions and advised to call clinic if any questions or concerns.